MHP Mischief Wins Global Campaign for World Bladder Cancer Patient Coalition
MHP Mischief has been appointed by the World Bladder Cancer Patient Coalition (WBCPC) – which brings together 11 patient organisations from four continents – to promote greater global awareness about bladder cancer and end its status as a ‘forgotten cancer’.
Established in 2019 the WBCPC seeks to unite the vision and goals of bladder cancer patient organisations to ensure the best possible outcomes for bladder cancer patients across the world. It advocates for the best possible support, information and care for people affected by the disease, no matter where they live in the world.
Following a competitive pitch process, MHP Mischief has been appointed as the Coalition’s global communications and engagement agency.
Led by the agency’s Senior Director (Patient Advocacy) Alison Dunlop and Head of Studio Gemma Irvine, the team will run a creative communications campaign during World Bladder Cancer Awareness Month in May 2022 to increase awareness by highlighting the facts about bladder cancer, promoting awareness of the symptoms, and calling for more research investment. The campaign is part of a 3-year programme under one creative umbrella, which carries different thematic focus each year that will translatable across regions and encourage participation from members of the coalition and beyond.
Alex Filicevas, Executive Director of World Bladder Cancer Patient Coalition (WBCPC), said:
“Since the establishment of the World Bladder Cancer Patient Coalition, we’ve been working to bring the community together and empower bladder cancer patient voices as we raise awareness worldwide.
“As we hopefully return to Bladder Cancer Awareness Month in 2022 post-pandemic, we want this step to be big, impactful and set a new path for our community.
“MHP Mischief has shown it understands our vision and can amplify our message and make these findings accessible to all.”
Alison Dunlop, Senior Director (Patient Advocacy) at MHP Mischief, said:
“We’re delighted to have been appointed by the World Bladder Cancer Patient Coalition and its partners at the beginning of this important journey.
“Bladder Cancer can no longer be a ‘forgotten cancer’ and we are looking forward to working with the WBCPC to raised awareness of the disease and help build a strong community of bladder cancer patient advocates around the world. Our integrated approach allows us to bring leading experts across the business to deliver on this unique challenge.”